Stanford researchers take a major step toward curing Type 1 diabetes
Type 1 diabetes cure research took a significant step forward as Stanford University scientists demonstrated a hybrid approach combining gene therapy and immune system retraining to protect insulin-producing beta cells. Rather than simply replacing destroyed cells, the method attempts to retrain the immune system to stop attacking them — targeting the root cause of the disease. In preclinical animal trials, the approach restored normal blood sugar regulation without requiring lifelong immunosuppressant drugs. For the millions living with this demanding, costly condition, the findings represent meaningful progress toward a functional cure.
